Erythropoietin or Darbepoetin for patients with cancer ‐ meta‐analysis based on individual patient data

BACKGROUND: Erythropoiesis‐stimulating agents (ESAs) reduce anemia in cancer patients and may improve quality of life, but there are concerns that ESAs might increase mortality. OBJECTIVES: Our objectives were to examine the effect of ESAs and identify factors that modify the effects of ESAs on over...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cochrane Database Syst Rev
Main Authors: Bohlius, Julia, Schmidlin, Kurt, Brillant, Corinne, Schwarzer, Guido, Trelle, Sven, Seidenfeld, Jerome, Zwahlen, Marcel, Clarke, Mike J, Weingart, Olaf, Kluge, Sabine, Piper, Margaret, Napoli, Maryann, Rades, Dirk, Steensma, David, Djulbegovic, Benjamin, Fey, Martin F, Ray‐Coquard, Isabelle, Moebus, Volker, Thomas, Gillian, Untch, Michael, Schumacher, Martin, Egger, Matthias, Engert, Andreas
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Ltd 2009
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7208183/
https://ncbi.nlm.nih.gov/pubmed/19588423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007303.pub2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados